Profile

Ares Life Sciences is a Jersey based life science investment partnership established in 2008 with the backing of the Bertarelli family, which over three generations turned Serono into one of the world’s biotech leaders.

The firm invests exclusively in revenue-generating life science companies, primarily in Europe, with presence or the capacity to expand internationally, especially in the emerging markets.

Ares Life Sciences is focused on long-term value creation without the need for a defined exit horizon, and plays an active role in building and expanding the companies it invests in through Board-level support. It is advised by a team of experienced life science and investment executives.